Extrapyramidal reactions in children treated with metoclopramide

Francesca Menniti-Ippolito, G. Traversa, R. Da Cas, R. Rossi, S. Renna, P. Barabino, G. Saggiomo, F. Vetrano, L. Sagliocca

Research output: Contribution to journalArticlepeer-review


Aim. Metoclopramide is used worldwide for the treatment of nausea and vomiting. Our study provides an estimate of the risk of extrapyramidal symptoms in children using metoclopramide. Patients and Methods. In a surveillance program of adverse drug reactions, children hospitalised for neurological disorders (cases) or for other acute conditions (controls) were compared with regard to the use of metoclopramide. Results. Out of 930 children (407 cases and 523 controls), 13 were hospitalised for extrapyramidal symptoms. Nine children with extrapyramidal symptoms, and 3 of the 523 controls, had used metoclopramide for the treatment of nausea and vomiting associated with fever and/or influenza (odds ratio 390; 95% confidence interval 61-2807). Discussion. This study provides strong evidence for the role of metoclopramide in the occurrence of extrapyramidal symptoms in children and suggests a reconsideration of the benefit-risk profile of this drug in the treatment of minor conditions.

Original languageEnglish
Pages (from-to)49-52
Number of pages4
JournalItalian Journal of Pediatrics
Issue number1
Publication statusPublished - Feb 2004


  • Adverse drug reactions in children
  • Extrapyramidal symptoms
  • Metoclopramide

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Extrapyramidal reactions in children treated with metoclopramide'. Together they form a unique fingerprint.

Cite this